Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. For a while, MDMA looked poised to make history. After decades of advocacy from impassioned supporters, the party drug best known ...

An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD. A U.S. Food and Drug Administration advisory committee voted on Tuesday ...

In a decision that shocked some observers, key advisers to the US Food and Drug Administration (FDA) voted that the effectiveness of the party drug MDMA for treating post-traumatic stress disorder is ...

The psychedelic drug MDMA is near the end of a decades-long effort to enter mainstream medicine but instead of celebrating, supporters now find themselves wondering if the treatment will actually make ...

Rick Doblin spent more than 30 years trying to turn the psychedelic drug MDMA into an accepted medical treatment for post-traumatic stress disorder. Earlier this month, the Food and Drug ...

After a remarkably sensational regulatory drug review, advisers for the Food and Drug Administration on Tuesday voted overwhelmingly against approving midomafetamine (MDMA, aka ecstasy or molly) as ...

Since emerging in prominence on the party scene in the 1980s, ecstasy has become a staple of festival and rave culture. But the drug also carries far more risks today than it did back then − and some ...

Also known as molly or ecstasy, MDMA has the potential to treat post-traumatic stress disorder (PTSD). But psychedelic-assisted therapy can only be administered by a trained professional. Without the ...

Credit: Getty Images. Significant factors limit MDMA’s ability to be used in the treatment of post-traumatic stress disorder. Significant factors limit MDMA’s ability to be used in the treatment of ...

A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...